Avalo Therapeutics Inc
(FRA:C6K0)
€
11.4
0.4 (3.64%)
Market Cap: 11.86 Mil
Enterprise Value: -78.22 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 49/100 Avalo Therapeutics Inc (FRA:C6K0) Transcripts
- Avalo Therapeutics Inc Annual Shareholders Meeting TranscriptDec 20, 2023
- Avalo Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Avalo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Avalo Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Avalo Therapeutics Inc Annual Shareholders Meeting TranscriptJun 14, 2022
- Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation TranscriptOct 19, 2021
- Cerecor Inc Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients - Corporate Call TranscriptJul 26, 2021
- Aytu BioScience Inc Acquires Prescription Product Portfolio from Cerecor Inc - M&A Call TranscriptOct 14, 2019
- 1